These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36583462)

  • 61. Compassionate Drug Use - Time Arising for a New Law in Bulgaria in the Era of COVID-19.
    Dzhafer N; Papathanasiou JV
    Folia Med (Plovdiv); 2020 Sep; 62(3):592-596. PubMed ID: 33009760
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Drug prescriptions study in the outpatient setting: assessment of off-label uses in children].
    Blanco-Reina E; Vega-Jiménez MA; Ocaña-Riola R; Márquez-Romero EI; Bellido-Estévez I
    Aten Primaria; 2015; 47(6):344-50. PubMed ID: 25443768
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Off-label drug prescribing in a Portuguese paediatric emergency unit.
    Ribeiro M; Jorge A; Macedo AF
    Int J Clin Pharm; 2013 Feb; 35(1):30-6. PubMed ID: 23054136
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Off-label prescribing of psychotropic drugs in a Danish child and adolescent psychiatric outpatient clinic.
    Nielsen ES; Hellfritzsch M; Sørensen MJ; Rasmussen H; Thomsen PH; Laursen T
    Eur Child Adolesc Psychiatry; 2016 Jan; 25(1):25-31. PubMed ID: 25724547
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Off-Label Prescribing of Antipsychotics in a Danish Child and Adolescent Mental Health Center: A Register-Based Study.
    Kornø KT; Aagaard L
    J Res Pharm Pract; 2018; 7(4):205-209. PubMed ID: 30622989
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Survey of off-label prescribing in a university paediatric outpatient in Brazil.
    Monteiro FASG; Soares CN; Chaveiro LG; Cabral VA; Lima PMA
    Trop Doct; 2022 Apr; 52(2):270-275. PubMed ID: 35037806
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Real-World Analysis of Off-Label Use of Molecularly Targeted Therapy in a Large Academic Medical Center Cohort.
    Upadhyay VA; Johnson BE; Landman AB; Hassett MJ
    JCO Precis Oncol; 2022 Jan; 6():e2100232. PubMed ID: 35050710
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence.
    Czaja AS; Valuck R
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):997-1004. PubMed ID: 22760843
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.
    Eguale T; Buckeridge DL; Verma A; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
    JAMA Intern Med; 2016 Jan; 176(1):55-63. PubMed ID: 26523731
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Drug utilization pattern in children and off-label use of medicines in a pediatric intensive care unit.
    Blanco-Reina E; Medina-Claros AF; Vega-Jiménez MA; Ocaña-Riola R; Márquez-Romero EI; Ruiz-Extremera Á
    Med Intensiva; 2016; 40(1):1-8. PubMed ID: 25583042
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Off-label antidepressant prescription in pediatric outpatients based on China Food and Drug Administration and Food and Drug Administration regulations: a Chinese retrospective study.
    Deng S; Zhu X; Sun B; Hu J; Shang D; Chen W; Lu H; Ni X; Zhang M; Wang Z; Wen Y; Qiu C
    Int Clin Psychopharmacol; 2018 May; 33(3):172-179. PubMed ID: 29505485
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Off-label use of rituximab in autoimmune disease in the Top End of the Northern Territory, 2008-2016.
    Wongseelashote S; Tayal V; Bourke PF
    Intern Med J; 2018 Feb; 48(2):165-172. PubMed ID: 28742259
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Compassionate use of off-label drugs: need for a change in Spain].
    Avendaño Solá C
    Med Clin (Barc); 2009 Sep; 133(11):425-6. PubMed ID: 19766261
    [No Abstract]   [Full Text] [Related]  

  • 74. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Off-label Medication Prescribing Patterns in Pediatrics: An Update.
    Yackey K; Stukus K; Cohen D; Kline D; Zhao S; Stanley R
    Hosp Pediatr; 2019 Mar; 9(3):186-193. PubMed ID: 30745323
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study.
    Cuzzolin L; Agostino R
    Eur J Clin Pharmacol; 2016 Jan; 72(1):117-23. PubMed ID: 26490354
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety profile of modafinil across a range of prescribing indications, including off-label use, in a primary care setting in England: results of a modified prescription-event monitoring study.
    Davies M; Wilton L; Shakir S
    Drug Saf; 2013 Apr; 36(4):237-46. PubMed ID: 23483377
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care--a nationwide study.
    Olsson J; Kimland E; Pettersson S; Odlind V
    Acta Paediatr; 2011 Sep; 100(9):1272-5. PubMed ID: 21438922
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular-Guided Off-Label Targeted Therapy in a Large-Scale Precision Oncology Program.
    Vashistha V; Katsoulakis E; Guo A; Price M; Ahmed S; Kelley MJ
    JCO Precis Oncol; 2023 Feb; 7():e2200518. PubMed ID: 36787508
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Off-label prescribing for children with chronic diseases in Nigeria; findings and implications.
    Oshikoya KA; Oreagba IA; Godman B; Fadare J; Orubu S; Massele A; Senbanjo IO
    Expert Opin Drug Saf; 2017 Sep; 16(9):981-988. PubMed ID: 28627939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.